Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

0.5141
Delayed Data
As of Feb 24
 +0.0131 / +2.61%
Today’s Change
0.41
Today|||52-Week Range
2.24
-19.26%
Year-to-Date
No recent news for MannKind Corp.

Today’s Trading

Previous close0.50
Today’s open0.50
Day’s range0.49 - 0.52
Volume1,580,787
Average volume (3 months)4,943,824
Market cap$239.8M
Dividend yield--
Data as of 3:59pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-78.43%
Earnings growth (this year)+112.64%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
TTPHTetraphase Pharmaceu...+0.13+2.50%
OCULOcular Therapeutix I...-0.07-0.85%
PETXAratana Therapeutics...-0.04-0.61%
CMRXChimerix Inc+0.09+1.68%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$0.00
Annual profit (last year)-$368.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs